Rosa L. Vincent
About
In The Last Decade
Rosa L. Vincent
10 papers receiving 775 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Biotechnology 454
- Biomedical Engineering 371
- Molecular Biology 263
- Oncology 191
- Immunology 138
Countries citing papers authored by Rosa L. Vincent
This map shows the geographic impact of Rosa L. Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa L. Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa L. Vincent more than expected).
Fields of papers citing papers by Rosa L. Vincent
This network shows the impact of papers produced by Rosa L. Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa L. Vincent. The network helps show where Rosa L. Vincent may publish in the future.
Co-authorship network of co-authors of Rosa L. Vincent
This figure shows the co-authorship network connecting the top 25 collaborators of Rosa L. Vincent. A scholar is included among the top collaborators of Rosa L. Vincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa L. Vincent. Rosa L. Vincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 13 | |
| 3 | Probiotic neoantigen delivery vectors for precision cancer immunotherapy breakdown → | 70 |
| 4 | 2 | |
| 5 | Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity breakdown → | 96 |
| 6 | Probiotic-guided CAR-T cells for solid tumor targeting breakdown → | 146 |
| 7 | Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies breakdown → | 420 |
| 8 | 5 | |
| 9 | 26 | |
| 10 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.